Reportlinker Adds Epidemiology: Rheumatoid Arthritis

NEW YORK, April 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Epidemiology: Rheumatoid Arthritis

http://www.reportlinker.com/p0484919/Epidemiology-Rheumatoid-Arthritis.html

Globally, between 0.2% and 1.2% of the world population above the age of 16 years has rheumatoid arthritis. In 2010, there were approximately 4.6 million people with rheumatoid arthritis in the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK). More than half of rheumatoid arthritis cases in the seven major markets (2.6 million) in 2010 were in the US alone. Datamonitor esGain insight to market potential, including a robust 10-year epidemiology forecast of rheumatoid arthritis prevalent cases.Understand the key epidemiologic risk factors associated with rheumatoid arthritis.In 2010, there were 4.6 million cases of rheumatoid arthritis prevalent cases in the seven major markets.Rheumatoid prevalent cases will marginally increase across the seven major markets although declines are estimated for Japan in the next 10 years.Aging populations are behind this rise in prevalent cases of rheumatoid arthritis.What is the estimated prevalence of rheumatoid arthritis in the seven major markets?What is the expected prevalence in the next 2010?

Executive Summary

Modest increases in rheumatoid arthritis prevalent cases

OVERVIEW

Catalyst

Summary

DISEASE DEFINITION AND DIAGNOSIS CRITERIA

Module scope

GLOBAL VARIATION AND HISTORICAL TRENDS

Contemporary trends

COMORBIDITIES OF RHEUMATOID ARTHRITIS

The major cause of disability

RISK FACTORS

Risks are largely unknown

EPIDEMIOLOGIC FORECASTING OF RHEUMATOID ARTHRITIS

Sources of epidemiologic data

Description of methods

US

Japan

France

Germany

Italy

Spain

UK

EPIDEMIOLOGIC FORECAST RESULTS

Estimated rheumatoid arthritis prevalent cases

DISCUSSION

Strengths and limitations of Datamonitor's epidemiologic projections

Conclusions

APPENDIX

Module methodology

To order this report:

: Epidemiology: Rheumatoid Arthritis

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Suggested Articles

A $300M pandemic ad campaign may be falling apart as HHS employees push back, celebrities balk and agency brass push a rushed timeline, Politico says.

With a pack of drugmakers angling for COVID-19 vaccine approvals in the coming months, the task of global distribution is more important than ever. Wi

"We have a chance to improve our reputation if we deliver on our purpose to find solutions responsibly," GSK CEO Emma Walmsley said.